Christian Behrenbruch Biography

Dr. Christian Behrenbruch is a Bioscience Entrepreneur & CEO of Telx Pharmaceuticals Limited, a clinical-stage biotechnology company dedicated to developing a pipeline of advanced "theranostic", diagnostic and therapeutic, assets for a number of unmet needs in cancer care.

Behrenbruch has twenty years of healthcare entrepreneurship and executive leadership experience. He has previously served in a CEO or Executive Director capacity at Mirada Solutions, CTI Molecular Imaging (now Siemens Healthcare), Fibron Technologies and ImaginAb, Inc.

As well, he a formerly served as Director of Momentum Biosciences LLC, Siemens Molecular Imaging Ltd, Radius Health Ltd (now Adaptix) and was the former Chairman of Cell Therapies P/L.

He is a director of Factor Therapeutics and Amplia Therapeutics P/L, a Chairman of the Monash Engineering and IT Foundation Board, and is an Adjunct Professor at Monash University.

Behrenbruch holds a Ph.D. in biomedical engineering from the University of Oxford, an executive MBA jointly awarded from New York University, HEC Paris and the London School of Economics and a Juris Doctor from the University of Melbourne.

As a renowned expert and highly sought-after speaker, Christian Behrenbruch's expertise is in high demand. To book Christian Behrenbruch for your next event, conference, or workshop, please contact our speaker booking agency. Our experienced team will work closely with you to understand your specific needs and help secure Christian Behrenbruch's participation. With our professional guidance and seamless booking process, you can ensure a memorable and impactful experience for your audience. Don't miss the opportunity to engage your audience with Christian Behrenbruch's compelling insights and inspire positive change within your organization. Fill out the booking request form to take the first step in securing Christian Behrenbruch for your next speaking engagement.